Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20(8):637–48.
Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Pharmacoeconomics. 1999;15(5):423–34.
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464–75.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, Heagerty PJ, Huang SS, James KT, Jarvik JG, et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol. 2017;17(1):144.
Makady A, de Boer A, Hillege H, Klungel O, Goettsch W. What is real-World Data? A review of definitions based on literature and stakeholder interviews. Value Health. 2017;20(7):858–65.
Friedman C, Rubin J, Brown J, Buntin M, Corn M, Etheredge L, Gunter C, Musen M, Platt R, Stead W, et al. Toward a science of learning systems: a research agenda for the high-functioning Learning Health System. J Am Med Inf Association. 2015;22(1):43–50.
Platt JE, Raj M, Wienroth M. An analysis of the Learning Health System in its first decade in practice: scoping review. J Med Internet Res. 2020;22(3):e17026.
Pomare C, Mahmoud Z, Vedovi A, Ellis LA, Knaggs G, Smith CL, Zurynski Y, Braithwaite J. Learning health systems: a review of key topic areas and bibliometric trends. Learn Health Syst. 2022;6(1):e10265.
Enticott J, Braaf S, Johnson A, Jones A, Teede HJ. Leaders’ perspectives on learning health systems: a qualitative study. BMC Health Serv Res. 2020;20(1):1087.
Forrest CB, McTigue KM, Hernandez AF, Cohen LW, Cruz H, Haynes K, Kaushal R, Kho AN, Marsolo KA, Nair VP, et al. PCORnet(R) 2020: current state, accomplishments, and future directions. J Clin Epidemiol. 2021;129:60–7.
Tarabichi Y, Frees A, Honeywell S, Huang C, Naidech AM, Moore JH, Kaelber DC. The Cosmos Collaborative: a vendor-facilitated Electronic Health Record Data Aggregation platform. ACI open. 2021;5(1):e36–46.
Policies and Technology for Interoperability and, Reduction B. [https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index]].
A Turning Point in Electronic Health Information Progress. [https://www.healthit.gov/buzz-blog/health-it-policy/a-turning-point-in-electronic-health-information-progress].
Lau C, Jamali F, Loebenberg R. Health Canada Usage of Real World Evidence (RWE) in Regulatory decision making compared with FDA/EMA usage based on publicly available information. J Pharm Pharm Sci. 2022;25:227–36.
Concato J, Corrigan-Curay J. Real-world evidence – where are we now? N Engl J Med. 2022;386(18):1680–2.
Real-World Evidence. Food and Drug Administation. [https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence].
Gatto NM, Reynolds RF, Campbell UB. A structured preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real-World evidence for Regulatory decisions. Clin Pharmacol Ther. 2019;106(1):103–15.
Gatto NM, Campbell UB, Rubinstein E, Jaksa A, Mattox P, Mo J, Reynolds RF. The structured process to identify fit-for-purpose data: A Data Feasibility Assessment Framework. Clin Pharmacol Ther. 2022;111(1):122–34.
Coste A, Wong A, Bokern M, Bate A, Douglas IJ. Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review. Pharmacoepidemiol Drug Saf. 2023;32(1):28–43.
Nie X, Jia L, Peng X, Zhao H, Yu Y, Chen Z, Zhang L, Cheng X, Lyu Y, Cao W, et al. Detection of Drug-Induced Thrombocytopenia signals in children using Routine Electronic Medical records. Front Pharmacol. 2021;12:756207.
Raman SR, Qualls LG, Hammill BG, Nelson AJ, Nilles EK, Marsolo K, O’Brien EC. Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial. Trials. 2023;24(1):566.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.
Wolfenden L, Williams CM, Wiggers J, Nathan N, Yoong SL. Improving the translation of health promotion interventions using effectiveness-implementation hybrid designs in program evaluations. Health Promot J Austr. 2016;27(3):204–7.
Root HJ, Lininger MR, DiStefano LJ. Hybrid effectiveness-implementation study designs in sports injury prevention research. Front Sports Act Living. 2022;4: 981656.
Green BB, Coronado GD, Schwartz M, Coury J, Baldwin LM. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice. Implement Sci. 2019;14(1):53.
Perry CK, Damschroder LJ, Hemler JR, Woodson TT, Ono SS, Cohen DJ. Specifying and comparing implementation strategies across seven large implementation interventions: a practical application of theory. Implement Sci. 2019;14(1):32.
Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8:139.
Pamungkas RA, Usman AM, Chamroonsawasdi K, Abdurrasyid. A smartphone application of Diabetes coaching intervention to prevent the onset of Complications and to improve Diabetes self-management: a randomized control trial. Diabetes Metab Syndr. 2022;16(7):102537.
Woodard L, Amspoker AB, Hundt NE, Gordon HS, Hertz B, Odom E, Utech A, Razjouyan J, Rajan SS, Kamdar N, et al. Comparison of collaborative goal setting with enhanced education for managing Diabetes-Associated distress and hemoglobin A1c levels: a Randomized Clinical Trial. JAMA Netw Open. 2022;5(5):e229975.
MacBride-Stewart S, Marwick C, Ryan M, Guthrie B. Feedback of actionable individual patient prescription data to improve Asthma prescribing: pragmatic cluster randomised trial in 233 UK general practices. Br J Gen Pract. 2022;72(722):e627-33.
Romani ED, Siddharthan T, Lovaton N, Alvitez-Luna CC, Flores-Flores O, Pollard SL. Implementation of an intervention to improve the adoption of Asthma self-management practices in Peru: Asthma implementation research (AIRE) randomized trial study protocol. Trials. 2020;21(1):377.
Lobo EH, Karmakar C, Abdelrazek M, Abawajy J, Chow CK, Zhang Y, Kabir MA, Daryabeygi R, Maddison R, Islam SMS. Design and development of a smartphone app for Hypertension management: an intervention mapping approach. Front Public Health. 2023;11:1092755.
Valerio-Shewmaker MA, Heredia NI, Pulicken C, Mathews PD, Chenier R, Swoboda TL, Garza ER, Velasco-Huerta F, Fernandez ME. Using implementation mapping for the adoption and implementation of target:BP in community health centers. Front Public Health. 2022;10:928148.
Pandey DK, Dasgupta R, Levy J, Wang H, Serafini A, Habibi M, Song W, Shafer PO, Loeb JA. Enhancing Epilepsy self-management and quality of life for adults with Epilepsy with varying social and educational backgrounds using PAUSE to learn your Epilepsy. Epilepsy Behav. 2020;111:107228.
Schougaard LMV, Mejdahl CT, Christensen J, Lomborg K, Maindal HT, de Thurah A, Hjollund NH. Patient-initiated versus fixed-interval patient-reported outcome-based follow-up in outpatients with Epilepsy: a pragmatic randomized controlled trial. J Patient Rep Outcomes. 2019;3(1):61.
Ridsdale L, Wojewodka G, Robinson EJ, Noble AJ, Morgan M, Taylor SJC, McCrone P, Richardson MP, Baker G, Landau S, et al. The effectiveness of a group self-management education course for adults with poorly controlled Epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia. 2018;59(5):1048–61.
Ghearing GR, Briggs F, Cassidy K, Privitera M, Blixen C, Sajatovic M. A randomized controlled trial of self-management for people with Epilepsy and a history of negative health events (SMART) targeting rural and underserved people with Epilepsy: a methodologic report. Trials. 2021;22(1):821.
Moore N, Blin P, Droz C. Pharmacoepidemiology. Handb Exp Pharmacol. 2019;260:433–51.
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887–92.
Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schunemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. 2011;4:MR000012.
Ankarfeldt MZ, Adalsteinsson E, Groenwold RH, Ali MS, Klungel OH. A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering Drugs. Clin Epidemiol. 2017;9:41–51.
Tonin FS, Steimbach LM, Leonart LP, Ferreira VL, Borba HH, Piazza T, Araujo AG, Fernandez-Llimos F, Pontarolo R, Wiens A. Discontinuation of non-anti-TNF Drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(11):1513–21.
Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342(25):1878–86.
Coscia C, Jaureguizar A, Quezada CA, Muriel A, Monreal M, Villen T, Barbero E, Chiluiza D, Yusen RD, Jimenez D. Comparison of all-cause Mortality following VTE Treatment between Propensity score-adjusted observational studies and matched randomized controlled trials: Meta-epidemiologic study. Chest. 2019;155(4):689–98.
Huynh T, Perron S, O’Loughlin J, Joseph L, Labrecque M, Tu JV, Theroux P. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation Myocardial Infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation. 2009;119(24):3101–9.
Li G, Holbrook A, Jin Y, Zhang Y, Levine MA, Mbuagbaw L, Witt DM, Crowther M, Connolly S, Chai-Adisaksopha C, et al. Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. Eur J Epidemiol. 2016;31(6):541–61.
Liu HY, Han Y, Chen XS, Bai L, Guo SP, Li L, Wu P, Yin YP. Comparison of efficacy of treatments for early Syphilis: a systematic review and network meta-analysis of randomized controlled trials and observational studies. PLoS One. 2017;12(6):e0180001.
Naudet F, Maria AS, Falissard B. Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies. PLoS One. 2011;6(6):e20811.
Shikata S, Nakayama T, Noguchi Y, Taji Y, Yamagishi H. Comparison of effects in randomized controlled trials with observational studies in digestive Surgery. Ann Surg. 2006;244(5):668–76.
Smeeing DPJ, van der Ven DJC, Hietbrink F, Timmers TK, van Heijl M, Kruyt MC, Groenwold RHH, van der Meijden OAJ, Houwert RM. Surgical Versus Nonsurgical Treatment for Midshaft Clavicle Fractures in patients aged 16 years and older: a systematic review, Meta-analysis, and comparison of Randomized controlled trials and observational studies. Am J Sports Med. 2017;45(8):1937–45.
Zhai C, Cong H, Hou K, Hu Y, Zhang J, Zhang Y. Clinical outcome comparison of percutaneous coronary intervention and bypass Surgery in diabetic patients with coronary artery Disease: a meta-analysis of randomized controlled trials and observational studies. Diabetol Metab Syndr. 2019;11:110.
Janiaud P, Agarwal A, Tzoulaki I, Theodoratou E, Tsilidis KK, Evangelou E, Ioannidis JPA. Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics. BMC Med. 2021;19(1):157.
Hong YD, Jansen JP, Guerino J, Berger ML, Crown W, Goettsch WG, Mullins CD, Willke RJ, Orsini LS. Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials. BMC Med. 2021;19(1):307.
Usman MS, Van Spall HGC, Greene SJ, Pandey A, McGuire DK, Ali ZA, Mentz RJ, Fonarow GC, Spertus JA, Anker SD, et al. The need for increased Pragmatism in cardiovascular clinical trials. Nat Reviews Cardiol. 2022;19(11):737–50.
Pencina MJ, Rockhold FW, D’Agostino RB. Deriving real-world insights from real-World Data: Biostatistics to the rescue. Ann Intern Med. 2018;169(6):401–2.
Moberg J, Kramer M. A brief history of the cluster randomized trial design. In: JLL (James Lind Library) Bulletin: Commentaries on the history of treatment evaluation. 2015.
Hallett J, Feng D, McCormick A, Allen S, Inouye J, Schure M, Holder S, Medicine LO, Held S. Improving chronic Illness self-management with the Apsaalooke Nation: the Baa Nnilah Project, a cluster randomized trial protocol. Contemp Clin Trials. 2022;119:106835.
Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391.
Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:54.
Nguyen AM, Cleland CM, Dickinson LM, Barry MP, Cykert S, Duffy FD, Kuzel AJ, Lindner SR, Parchman ML, Shelley DR, et al. Considerations before selecting a stepped-Wedge Cluster Randomized Trial Design for a practice improvement study. Ann Fam Med. 2022;20(3):255–61.
Li YH, Mullette E, Brant JM. The stepped-Wedge Trial Design: paving the way for Cancer Care Delivery Research. J Adv Pract Oncol. 2018;9(7):722–7.
Beard E, Lewis JJ, Copas A, Davey C, Osrin D, Baio G, Thompson JA, Fielding KL, Omar RZ, Ononge S, et al. Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014. Trials. 2015;16:353.
Wester V, de Groot S, Kanters T, Wagner L, Ardesch J, Corro Ramos I, Enders-Slegers MJ, de Ruiter M, le Cessie S, Los J, et al. Evaluating the effectiveness and cost-effectiveness of seizure dogs in persons with medically refractory Epilepsy in the Netherlands: study protocol for a stepped Wedge Randomized Controlled Trial (EPISODE). Front Neurol. 2020;11:3.
Galbraith S, Marschner IC. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. Stat Med. 2003;22(11):1787–805.
Parsons NR, Stallard N, Parsons H, Haque A, Underwood M, Mason J, Khan I, Costa ML, Griffin DR, Griffin J, et al. Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs. BMC Med Res Methodol. 2022;22(1):256.
Group sequential design. [https://toolbox.eupati.eu/glossary/group-sequential-design/].
Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world Clinical Data for the practicing clinician. Adv Ther. 2018;35(11):1763–74.
Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. 2022;22(1):287.
Agniel D, Kohane IS, Weber GM. Biases in electronic health record data due to processes within the healthcare system: retrospective observational study. BMJ. 2018;361:k1479.
Kohane IS, Aronow BJ, Avillach P, Beaulieu-Jones BK, Bellazzi R, Bradford RL, Brat GA, Cannataro M, Cimino JJ, García-Barrio N, et al. What every reader should know about studies using Electronic Health Record Data but May be afraid to ask. J Med Internet Res. 2021;23(3):e22219.
Gokhale M, Stürmer T, Buse JB. Real-world evidence: the devil is in the detail. Diabetologia. 2020;63(9):1694–705.
von Lucadou M, Ganslandt T, Prokosch HU, Toddenroth D. Feasibility analysis of conducting observational studies with the electronic health record. BMC Med Inf Decis Mak. 2019;19(1):202.
Beesley LJ, Salvatore M, Fritsche LG, Pandit A, Rao A, Brummett C, Willer CJ, Lisabeth LD, Mukherjee B. The emerging landscape of health research based on biobanks linked to electronic health records: existing resources, statistical challenges, and potential opportunities. Stat Med. 2020;39(6):773–800.
Callahan A, Shah NH, Chen JH. Research and Reporting Considerations for Observational Studies Using Electronic Health Record Data. Ann Intern Med. 2020;172(11 Suppl):79-S84.
Holmes JH, Beinlich J, Boland MR, Bowles KH, Chen Y, Cook TS, Demiris G, Draugelis M, Fluharty L, Gabriel PE, et al. Why is the Electronic Health Record so challenging for Research and Clinical Care? Methods Inf Med. 2021;60(1–02):32–48.
Acton EK, Willis AW, Hennessy S. Core concepts in pharmacoepidemiology: key biases arising in pharmacoepidemiologic studies. Pharmacoepidemiol Drug Saf. 2023;32(1):9–18.
Lewis AE, Weiskopf N, Abrams ZB, Foraker R, Lai AM, Payne PRO, Gupta A. Electronic health record data quality assessment and tools: a systematic review. J Am Med Inf Association. 2023;30(10):1730–40.
Bykov K, Patorno E, D’Andrea E, He M, Lee H, Graff JS, Franklin JM. Prevalence of Avoidable and Bias-Inflicting Methodological pitfalls in Real-World studies of Medication Safety and Effectiveness. Clin Pharmacol Ther. 2022;111(1):209–17.
Xue TM, Pan W, Tsumura H, Wei S, Lee C, McConnell ES. Impact of Dementia on long-term hip fracture Surgery outcomes: an Electronic Health Record Analysis. J Am Med Dir Assoc. 2023;24(2):235-241e232.
Li F, Tian Z, Bobb J, Papadogeorgou G, Li F. Clarifying selection bias in cluster randomized trials. Clin Trials. 2022;19(1):33–41.
Goldstein ND, Kahal D, Testa K, Burstyn I. Inverse probability weighting for selection bias in a Delaware community health center electronic medical record study of community deprivation and Hepatitis C prevalence. Ann Epidemiol. 2021;60:1–7.
Beesley LJ, Mukherjee B. Statistical inference for association studies using electronic health records: handling both selection bias and outcome misclassification. Biometrics. 2022;78(1):214–26.
Hayakawa T, Nagashima T, Akimoto H, Minagawa K, Takahashi Y, Asai S. Benzodiazepine-related Dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records. Digit Health. 2023;9:20552076231178576.
Rafiq M, Abel G, Renzi C, Lyratzopoulos G. Steroid prescribing in primary care increases prior to Hodgkin Lymphoma diagnosis: a UK nationwide case-control study. Cancer Epidemiol. 2022;81: 102284.
Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifiro G, Matthews JN, Prieto-Merino D, Molokhia M, Pedersen L, Gini R, et al. Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care. 2012;50(10):890–7.
Groenwold RHH. Informative missingness in electronic health record systems: the curse of knowing. Diagn Progn Res. 2020;4:8.
Perez-Lebel A, Varoquaux G, Le Morvan M, Josse J, Poline JB. Benchmarking missing-values approaches for predictive models on health databases. Gigascience. 2022;11:11.
Patino CM, Ferreira JC. Internal and external validity: can you apply research study results to your patients? J Bras Pneumol. 2018;44(3):183.
Fawcett N, Young B, Peto L, Quan TP, Gillott R, Wu J, Middlemass C, Weston S, Crook DW, Peto TEA, et al. Caveat emptor’: the cautionary tale of endocarditis and the potential pitfalls of clinical coding data-an electronic health records study. BMC Med. 2019;17(1):169.
Weinstein EJ, Ritchey ME, Lo Re V 3rd. Core concepts in pharmacoepidemiology: validation of health outcomes of interest within real-world healthcare databases. Pharmacoepidemiol Drug Saf. 2023;32(1):1–8.
Cook LA, Sachs J, Weiskopf NG. The quality of social determinants data in the electronic health record: a systematic review. J Am Med Inf Association. 2021;29(1):187–96.
Goldstein ND, Kahal D, Testa K, Gracely EJ, Burstyn I. Data Quality in Electronic Health Record Research: an Approach for Validation and Quantitative Bias Analysis for Imperfectly Ascertained Health outcomes Via Diagnostic codes. Harv Data Sci Rev. 2022;4(2). https://doi.org/10.1162/99608f92.cbe67e91.
Vest JR, Adler-Milstein J, Gottlieb LM, Bian J, Campion TR Jr, Cohen GR, Donnelly N, Harper J, Huerta TR, Kansky JP, et al. Assessment of structured data elements for social risk factors. Am J Manag Care. 2022;28(1):e14–23.
Saez C, Gutierrez-Sacristan A, Kohane I, Garcia-Gomez JM, Avillach P. EHR temporal variability: delineating temporal data-set shifts in electronic health records. Gigascience. 2020;9(8):giaa079.
Zeng J, Gensheimer MF, Rubin DL, Athey S, Shachter RD. Uncovering interpretable potential confounders in electronic medical records. Nat Commun. 2022;13(1):1014.
Zhang L, Wang Y, Schuemie MJ, Blei DM, Hripcsak G. Adjusting for indirectly measured confounding using large-scale propensity score. J Biomed Inform. 2022;134:104204.
Zang H, Kim HJ, Huang B, Szczesniak R. Bayesian causal inference for observational studies with missingness in covariates and outcomes. Biometrics. 2023. https://doi.org/10.1111/biom.13918. Epub ahead of print.
Xiong R, Koenecke A, Powell M, Shen Z, Vogelstein JT, Athey S. Federated causal inference in heterogeneous observational data. Stat Med. 2023;42(24):4418–39.
Steinberg E, Ignatiadis N, Yadlowsky S, Xu Y, Shah N. Using public clinical trial reports to probe non-experimental causal inference methods. BMC Med Res Methodol. 2023;23(1):204.
Michoel T, Zhang JD. Causal inference in drug discovery and development. Drug Discov Today. 2023;28(10):103737.
Lane M, Berlin NL, Chung KC, Waljee JF. Strengthening Association through Causal Inference. Plast Reconstr Surg. 2023;152(4):899–907.
Hufstedler H, Mauer N, Yeboah E, Carr S, Rahman S, Danzer AM, Debray TPA, Jong VMT, Campbell H, Gustafson P, et al. Application of causal inference methods to pooled Longitudinal non- Randomized studies: a methodological systematic review. Res Sq. 2023:rs.3.rs-3282208.
Common Data Elements. : Increasing FAIR Data Sharing. https://nexus.od.nih.gov/all/2021/06/24/common-data-elements-increasing-fair-data-sharing/.
Grinspan ZM, Patel AD, Shellhaas RA, Berg AT, Axeen ET, Bolton J, Clarke DF, Coryell J, Gaillard WD, Goodkin HP, et al. Design and implementation of electronic health record common data elements for pediatric Epilepsy: foundations for a learning health care system. Epilepsia. 2021;62(1):198–216.
Wyles CC, Fu S, Odum SL, Rowe T, Habet NA, Berry DJ, Lewallen DG, Maradit-Kremers H, Sohn S, Springer BD. External Validation of Natural Language Processing Algorithms to Extract Common Data Elements in THA Operative Notes. J Arthroplasty. 2023;38(10):2081-4.
Wang L, Fu S, Wen A, Ruan X, He H, Liu S, Moon S, Mai M, Riaz IB, Wang N, et al. Assessment of Electronic Health Record for Cancer Research and Patient Care through a scoping review of Cancer Natural Language Processing. JCO Clin Cancer Inform. 2022;6:e2200006.
Lyketsos CG, Roberts SB, Swift EK, Quina A, Moon G, Kremer I, Tariot P, Fillit H, Bovenkamp DE, Zandi PP, et al. Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and treatment. J Prev Alzheimers Dis. 2022;9(3):556–60.
Bradwell KR, Wooldridge JT, Amor B, Bennett TD, Anand A, Bremer C, Yoo YJ, Qian Z, Johnson SG, Pfaff ER, et al. Harmonizing units and values of quantitative data elements in a very large nationally pooled electronic health record (EHR) dataset. J Am Med Inf Association. 2022;29(7):1172–82.
Fitzgerald MP, Kaufman MC, Massey SL, Fridinger S, Prelack M, Ellis C, Ortiz-Gonzalez X, Fried LE, DiGiovine MP, Collaborative CPEP, et al. Assessing seizure burden in pediatric Epilepsy using an electronic medical record-based tool through a common data element approach. Epilepsia. 2021;62(7):1617–28.
Thandi M, Brown S, Wong ST. Mapping frailty concepts to SNOMED CT. Int J Med Inform. 2021;149:104409.
Hurst JH, Liu Y, Maxson PJ, Permar SR, Boulware LE, Goldstein BA. Development of an electronic health records datamart to support clinical and population health research. J Clin Transl Sci. 2020;5(1):e13.
Hammond WE, Bent B, West VL. Goodbye Electronic Health Record? Stud Health Technol Inform. 2022;298:107–11.
Clermont G. The Learning Electronic Health Record. Crit Care Clin. 2023;39(4):689–700.
Juhn Y, Liu H. Artificial intelligence approaches using natural language processing to advance EHR-based clinical research. J Allergy Clin Immunol. 2020;145(2):463–9.
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Revised Cochrane risk of bias tool for randomized trials (RoB 2.) Additional considerations for cluster-randomized trials (RoB 2 CRT) [https://drive.google.com/file/d/1yDQtDkrp68_8kJiIUdbongK99sx7RFI-/view.
Page MJ, Higgins JPT, Sterne JAC, et al. Chap. 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. 3rd ed. Chichester: John Wiley and Sons; 2019.
Risk Of Bias due to Missing Evidence (ROB-ME). : a new tool for assessing risk of non-reporting biases in evidence syntheses. [https://drive.google.com/file/d/1BaF3lZ6j1ZIx208gsoYab8uGzk6zlqvw/view].
Leather DA, Jones R, Woodcock A, Vestbo J, Jacques L, Thomas M. Real-World Data and Randomised controlled trials: the Salford Lung Study. Adv Ther. 2020;37(3):977–97.
Shortreed SM, Rutter CM, Cook AJ, Simon GE. Improving pragmatic clinical trial design using real-world data. Clin Trials. 2019;16(3):273–82.
Laaksonen N, Varjonen JM, Blomster M, Palomaki A, Vasankari T, Airaksinen J, Huupponen R, Scheinin M, Juuso B. Assessing an Electronic Health Record research platform for identification of clinical trial participants. Contemp Clin Trials Commun. 2021;21:100692.
Claerhout B, Kalra D, Mueller C, Singh G, Ammour N, Meloni L, Blomster J, Hopley M, Kafatos G, Garvey A, et al. Federated electronic health records research technology to support clinical trial protocol optimization: evidence from EHR4CR and the InSite platform. J Biomed Inform. 2019;90:103090.
Conley S, O’Connell M, Linsky S, Moemeka L, Darden JWt, Gaiser EC, Jacoby D, Yaggi H, Redeker NS. Evaluating recruitment strategies for a Randomized Clinical Trial with Heart Failure patients. West J Nurs Res. 2021;43(8):785–90.
Bennett WL, Bramante CT, Rothenberger SD, Kraschnewski JL, Herring SJ, Lent MR, Clark JM, Conroy MB, Lehmann H, Cappella N, et al. Patient recruitment into a Multicenter Clinical Cohort Linking Electronic Health Records from 5 Health Systems: cross-sectional analysis. J Med Internet Res. 2021;23(5):e24003.
Pfaff E, Lee A, Bradford R, Pae J, Potter C, Blue P, Knoepp P, Thompson K, Roumie CL, Crenshaw D, et al. Recruiting for a pragmatic trial using the electronic health record and patient portal: successes and lessons learned. J Am Med Inf Association. 2019;26(1):44–9.
Plante TB, Gleason KT, Miller HN, Charleston J, McArthur K, Himmelfarb CD, Lazo M, Ford DE, Miller ER 3rd, Appel LJ, et al. Recruitment of trial participants through electronic medical record patient portal messaging: a pilot study. Clin Trials. 2020;17(1):30–8.
Tabriz AA, Fleming PJ, Shin Y, Resnicow K, Jones RM, Flocke SA, Shires DA, Hawley ST, Willens D, Lafata JE. Challenges and opportunities using online portals to recruit diverse patients to behavioral trials. J Am Med Inf Association. 2019;26(12):1637–44.
Kannan V, Wilkinson KE, Varghese M, Lynch-Medick S, Willett DL, Bosler TA, Chu L, Gates SI, Holbein MEB, Willett MM, et al. Count me in: using a patient portal to minimize implicit bias in clinical research recruitment. J Am Med Inf Assoc. 2019;26(8–9):703–13.
Gehtland LM, Paquin RS, Andrews SM, Lee AM, Gwaltney A, Duparc M, Pfaff ER, Bailey DB Jr. Using a patient Portal to increase enrollment in a newborn Screening Research Study: Observational Study. JMIR Pediatr Parent. 2022;5(1):e30941.
Kim SY, Flory J, Relton C. Ethics and practice of trials within cohorts: an emerging pragmatic trial design. Clin Trials. 2018;15(1):9–16.
Verweij ME, Gal R, Burbach JPM, Young-Afat DA, van der Velden JM, van der Graaf R, May AM, Relton C, Intven MPW, Verkooijen HM. Most patients reported positively or neutrally of having served as controls in the trials within cohorts design. J Clin Epidemiol. 2022;148:39–47.
Young-Afat DA, Gal R, Gerlich S, Burbach JPM, van der Velden JM, van den Bongard D, Intven MPW, Kasperts N, May AM, van der Graaf R, et al. Oncology patients were found to understand and accept the trials within cohorts design. J Clin Epidemiol. 2021;130:135–42.
Zhang JZ, Nicholls SG, Carroll K, Nix HP, Goldstein CE, Hey SP, Brehaut JC, McLean PC, Weijer C, Fergusson DA, Taljaard M. Informed consent in pragmatic trials: results from a survey of trials published 2014-2019. J Med Ethics. 2021:medethics-2021-107765.
O’Rourke PP, Carrithers J, Patrick-Lake B, Rice TW, Corsmo J, Hart R, Drezner MK, Lantos JD. Harmonization and streamlining of research oversight for pragmatic clinical trials. Clin Trials. 2015;12(5):449–56.
Code of Federal Regulations. 45 CFR 46.116(d). Protection of Human Subjects. General Requirements for Informed Consent. [https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#46.116].
McKinney RE Jr, Beskow LM, Ford DE, Lantos JD, McCall J, Patrick-Lake B, Pletcher MJ, Rath B, Schmidt H, Weinfurt K. Use of altered informed consent in pragmatic clinical research. Clin Trials. 2015;12(5):494–502.
Kim SY, Kimmelman J. Practical steps to identifying the research risk of pragmatic trials. Clin Trials. 2022;19(2):211–6.
Lantos JD, Wendler D, Septimus E, Wahba S, Madigan R, Bliss G. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials. Clin Trials. 2015;12(5):485–93.
Miller DG, Kim SYH, Li X, Dickert NW, Flory J, Runge CP, Relton C. Ethical acceptability of postrandomization consent in pragmatic clinical trials. JAMA Netw Open. 2018;1(8):e186149.
Marquis-Gravel G, Robertson H, Jones WS, Riley D, Ford DE, Crenshaw D, Joosten YA, Rudov L, Hernandez AF, Hess R. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the aspirin dosing: a patient-centric trial assessing benefits and long-term effectiveness (ADAPTABLE) trial. Trials. 2021;22(1):90.
Federico CA, Heagerty PJ, Lantos J, O’Rourke P, Rahimzadeh V, Sugarman J, Weinfurt K, Wendler D, Wilfond BS, Magnus D. Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials. Contemp Clin Trials. 2022;115:106703.
Lakin JR, Brannen EN, Tulsky JA, Paasche-Orlow MK, Lindvall C, Chang Y, Gundersen DA, El-Jawahri A, Volandes A, Investigators A-P. Advance Care Planning: promoting effective and aligned communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer. BMJ Open. 2020;10(7):e040999.
van Oostveen RB, Romero-Palacios A, Whitlock R, Lee SF, Connolly S, Carignan A, Mazer CD, Loeb M, Mertz D. Prevention of Infections in Cardiac Surgery study (PICS): study protocol for a pragmatic cluster-randomized factorial crossover pilot trial. Trials. 2018;19(1):688.
Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, et al. The TiME trial: a fully embedded, Cluster-Randomized, pragmatic trial of Hemodialysis Session Duration. J Am Soc Nephrol. 2019;30(5):890–903.
Spector-Bagdady K, Trinidad G, Kardia S, Krenz CD, Nong P, Raj M, Platt JE. Reported interest in notification regarding use of Health Information and Biospecimens. JAMA. 2022;328(5):474–6.
Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, Taljaard M. The Ottawa Statement on the ethical Design and Conduct of Cluster Randomized trials. PLoS Med. 2012;9(11):e1001346.
International Ethical Guidelines for Health-related Research Involving Humans, Fourth Edition. Geneva. Council for International Organizations of Medical Sciences (CIOMS); 2016.
IRB waiver or. Alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators and institutional review boards. https://www.fda.gov/media/106587/download.
Nix HP, Weijer C, Brehaut JC, Forster D, Goldstein CE, Taljaard M. Informed consent in cluster randomised trials: a guide for the perplexed. BMJ Open. 2021;11(9):e054213.
Copas AJ, Lewis JJ, Thompson JA, Davey C, Baio G, Hargreaves JR. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials. 2015;16:352.
Hemming K, Taljaard M. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice? Int J Epidemiol. 2020;49(3):1043–52.
Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019;20(1):68.
Binik A. Delaying and withholding interventions: ethics and the stepped wedge trial. J Med Ethics. 2019;45(10):662–7.
Hughes JP, Granston TS, Heagerty PJ. Current issues in the design and analysis of stepped wedge trials. Contemp Clin Trials. 2015;45(Pt A):55–60.
Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614.
Eskola SM, Leufkens HGM, Bate A, De Bruin ML, Gardarsdottir H. Use of Real-World Data and evidence in Drug Development of Medicinal products centrally authorized in Europe in 2018–2019. Clin Pharmacol Ther. 2022;111(1):310–20.
Purpura CA, Garry EM, Honig N, Case A, Rassen JA. The role of real-world evidence in FDA-Approved New Drug and Biologics license applications. Clin Pharmacol Ther. 2022;111(1):135–44.
You SC, Krumholz HM. The evolution of evidence-based medicine: when the magic of the Randomized Clinical Trial meets real-World Data. Circulation. 2022;145(2):107–9.
Mackowiak JI, Mack CD, Irwin DE, Zura R. Randomized Clinical Trial or Real-World evidence: how historical events, public demand, and the resulting laws and regulations shaped the body of medical evidence. J Orthop Trauma. 2021;35(Suppl 1):17-S21.
Miksad RA, Abernethy AP. Harnessing the power of real-world evidence (RWE): a Checklist to Ensure Regulatory-Grade Data Quality. Clin Pharmacol Ther. 2018;103(2):202–5.
Sajatovic M, Wilson B, Shegog R, Escoffery FBSB, Jobst C, Johnson BC, Fraser EK, Quarells RT, Spruill RC. The managing Epilepsy Well (MEW) network database: lessons learned in refining and implementing an integrated data tool in service of a national U.S. Research Collaborative. Epilepsy Behav. 2021;115:107650.
Lhatoo SD, Bernasconi N, Blumcke I, Braun K, Buchhalter J, Denaxas S, Galanopoulou A, Josephson C, Kobow K, Lowenstein D, et al. Big data in Epilepsy: clinical and research considerations. Report from the Epilepsy Big Data Task Force of the International League against Epilepsy. Epilepsia. 2020;61(9):1869–83.
Karanatsios B, Prang KH, Verbunt E, Yeung JM, Kelaher M, Gibbs P. Defining key design elements of registry-based randomised controlled trials: a scoping review. Trials. 2020;21(1):552.
Concannon TW, Guise JM, Dolor RJ, Meissner P, Tunis S, Krishnan JA, Pace WD, Saltz J, Hersh WR, Michener L, et al. A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci. 2014;7(2):164–71.
Kumar K, Kumar P, Deb D, Unguresan ML, Muresan V. Artificial Intelligence and Machine Learning Based Intervention in Medical Infrastructure: a Review and Future trends. Healthc (Basel). 2023;11(2):207.
Sezgin E, Hussain SA, Rust S, Huang Y. Extracting Medical Information From Free-Text and Unstructured Patient-Generated Health Data Using Natural Language Processing Methods: Feasibility Study With Real-world Data. JMIR Form Res. 2023;7:e43014.
Negro-Calduch E, Azzopardi-Muscat N, Krishnamurthy RS, Novillo-Ortiz D. Technological progress in electronic health record system optimization: systematic review of systematic literature reviews. Int J Med Inform. 2021;152:104507.